MARKET

RLM

RLM

Realm Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.500
-0.010
-0.40%
Delisted 16:00 07/30 EDT
OPEN
2.560
PREV CLOSE
2.510
HIGH
2.760
LOW
2.450
VOLUME
94.05K
TURNOVER
--
52 WEEK HIGH
13.00
52 WEEK LOW
1.350
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RLM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

RLM News

  • 10 Biopharmaceutical Companies Trying To Cure Cancer
  • Benzinga.08/24 17:46
  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Realm Therapeutics plc to ESSA Pharma Inc., LLC is Fair to Shareholders
  • GlobeNewswire.05/20 16:35
  • ESSA Pharma to acquire Realm Therapeutics
  • seekingalpha.05/16 16:15
  • ESSA Pharma, Realm Therapeutics To Merge In $20M Deal
  • Benzinga.05/16 13:47

More

Hot Stocks

Name
Price
%Change

About RLM

Realm Therapeutics plc, formerly PuriCore plc, is a biopharmaceutical company. The Company is focused on leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company has initiated drug development programs based on its hypochlorous acid technology. The Company is engaged in the development of small molecule therapies with potential application for the treatment of diseases in a number of therapeutic areas, and an initial focus in dermatology and ophthalmology. The Company has developed proprietary formulations of its technology, with anti-inflammatory and immunomodulatory benefits. Its pipeline of products include PR013 and PR022, which are in Phase I. PR013 is indicated for allergic conjunctivitis and PR022 is indicated for atopic dermatitis. Realm Therapeutics, Inc. is a subsidiary of the Company.
More

Webull offers Realm Therapeutics PLC (RLM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.